Impact of digital substraction angiography by intravenous injection (DSAV) was examined in a private neurology clinic. In the evaluation of threatened stroke, advent of DSAV was associated with reduced use of both traditional noninvasive tests (from 100% of patients to 36%), and conventional arteriograms (from 29% to 4%). Less compelling indications were often prescreened with noninvasive tests; more compelling symptoms usually had initial DSAV. Conventional arteriograms were done for compelling indications and negative or inadequate DSAV. The average cost of evaluation was increased siightiy in patients treated medically and reduced greatly in those having surgery. While cost and convenience might support such utilization, issues of quality of evaluation require consideration.